Live feed
Filing
SC 13G
SC 13G0001683168-23-008109·Spyre Therapeutics, Inc.
Schedule 13G ownership disclosure
AEGLEA BIOTHERAPEUTICS INC
Security class unavailable · CUSIP: 00773J103
Event date: 2023-09-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 383,659
- Percent of class
- 9.4800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-23-008109
- Form type
- SC 13G
- Filer
- Spyre Therapeutics, Inc.
- CIK
- CIK 1636282
- Filed
- Nov 14, 2023
- Reporting period
- Sep 08, 2023
- Description
- Schedule 13G beneficial ownership